Abstract
The effects of olanzapine [LY 170053; 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2, 3b][1,5]benzodiazepine), a potential atypical antipsychotic, were determined in pigeons whose keypeck responding was punished. These effects were compared to the anxiolytic agents chlordiazepoxide and pentobarbital, and to other antipsychotic agents. Keypeck behavior was maintained under a multiple FR30 FR30 schedule, signalled by white and red stimulus lights, respectively. Each component of the schedule alternated every 3 min with a 30-s timeout. During the white keylight component, responding was maintained by food presentation. During the red keylight component, responding was maintained by food and simultaneously suppressed by electric shock presentation, with response rates being only about 5% of those during the white stimulus light. Olanzapine (0.01–1.0 mg/kg) increased punished responding at doses below those which had an effect on unpunished responding. Clozapine (0.01–1.0 mg/kg), ritanserin (0.1–3.0 mg/kg), and, to a lesser extent, risperidone (0.1–1.0 mg/kg) were also effective at increasing punished responding. Generally, the maximum effect seen with olanzapine was equal to that seen with ritanserin, and it exceeded that seen with clozapine. However, these effects were generally less than those seen with chlordiazepoxide and pentobarbital. Haloperidol (0.01–0.1 mg/kg) was completely without effect on punished responding, while it caused decreases in unpunished behavior. These results provide further evidence that olanzapine has a profile in behavioral tests unlike the typical antipsychotic haloperidol. Moreover, this profile is similar to clozapine, a clinically effective antipsychotic with an atypical profile.
Similar content being viewed by others
References
Azrin N (1959) A technique for delivering shock to pigeons. J Exp Anal Behav 2:161–163
Barrett JE (1992) Recent developments in animal models of anxiety and anxiolytic drugs. In: Mendlewicz J, Racagni G (eds) Target receptors for anxiolytic and hypnotics: from molecular pharmacology to therapeutics. Karger, Basel
Barrett JE, Witkin JM (1976) Interaction ofd-amphetamine with entobarbital and chlordiazepoxide: effects on punished responding behavior of pigeons. Pharmacol Biochem Behav 5:285–292
Barrett JE, Witkin JM (1988) Buspirone in animal models of anxiety. In: Tunnicliff G, Eison AS, Taylor DP (eds) Buspirone: mechanisms and clinical aspects. Academic Press, New York
Bleich A, Brown S, Kahn R, Van Praag HM (1988) The role of serotonin in schizophrenia. Schizophr Bull 14:297–315
Brocco MJ, Koek W, Degryse AD, Colpaert FC (1990) Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and ogel conflict procedures. Behav Pharmacol 1:403–418
Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 8:383–388
Coward DM (1991) Pharmacological approaches to the development of atypical antipsychotics. In: Tamminga CA, Schulz SC (eds) Schizophrenia research. Raven Press, New York, pp 297–306
Coward DM, Imperato A, Urwyler S, White TG (1989) Biochemical and behavioral properties of clozapine. Psychopharmacology 99:S6-S12
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483
Cuelemans DLS, Hoppenbrouwers M, Gelders YG, Reyntjens AJM (1985) The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303–305
Ekblom B, Haggstrom JE (1974) Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 16:945–957
Ferster CB, Skinner BF (1957) Schedules of reinforcement. Appleton Century-Crofts, New York
Fitton A, Heel RC (1990) Clozapine, a review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 40:722–747
Friedman RL, Sanders-Bush E, Barrett RJ (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106:191–193
Fuller RW, Mason NR (1985) Flumezapine, an antagonist of central dopamine and serotonin receptors. Res Commun Chem Pathol Pharmacol 54:23–27
Geller I, Seifter J (1960) The effects of meprobamate, barbiturates,d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482–492
Gerlach J, Koppelhus E, Helweg E, Monrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410–424
Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE (1989) Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809–817
Hippius H (1989) The history of clozapine. Psychopharmacology 99:S3-S5
Janssen PAJ, Niemegeers CJE, Awouters F, Schellekens KHL, Megens AAHP, Meert TF (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685–693
Kane J, Honigfeld G, Singer J, Meltzer HY (1988) Clozapine for the treatment-resistent schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789–796
Koek W, Jackson A, Colpaert FC (1992) Behavioral pharmacology of antagonists at 5-HT2/5-HT1Creceptors. Neurosci Biobehav Rev 16:95–105
Krupp P, Barnes P (1992) Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry 160 [supp]:38–41
Mansbach RS, Harrod C, Hoffman SM, Nader MA, Lei Z, Witkin JM, Barrett JE (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114–120
Meert TF, Janssen PAJ (1989) Psychopharmacology of ritanserin: comparison with chlordiazepoxide. Drug Dev Res 18:119–144
Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2:19–76
Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical drugs on the basis of dopamine D-1, D-2 and serotonin2. J Pharmacol Exp Ther 251:238–246
Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel “atypical” antipsychotic agent. J Pharmacol Exp Ther. 262:545–551
Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Inv Drugs, 2:281–293
Moore NA, Rees G, Sanger G, Tye NC (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5:196–202
Mosconi M, Chiamulera C, Recchia G (1993) New anxiolytics in development. Int J Clin Pharm Res XIII[6]:331–344
Rasmussen K, Aghajanian GK (1988) Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity. Neuropychopharmacology 2:101–107
Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridizine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97–101
Schmutz J, Eichenberger E (1982) Clozapine. Chronicles of Drug Discovery 1:39–59
Shader RI, Mascio A (1970) Psychotropic drug side effects: chemical and theoretical perspectives. Williams and Wilkins, Baltimore
Spealman RD, Katz JL (1980) Some effects of clozapine on punished responding by mice and squirrel monkeys. J Pharmacol Exp Ther 212:435–440
Stille G, Lauener H, Eichenberger E. (1971) The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzoiazepine (clozapine). II Farmaco 26:603–625
Wiley JL, Compton AD, Porter JH (1993) Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 45: 263–267
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benvenga, M.J., Leander, J.D. Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology 119, 133–138 (1995). https://doi.org/10.1007/BF02246153
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246153